德克托里丁调节代谢综合征中交织的分子通路:来自网络药理学,分子对接和体内研究的见解
Ashwini Kumar Mishra1,2, Pravat Kumar Sahoo3, Rajesh Singh4
1Department of Pharmaceutics, School of Pharmacy and Technology Management, SVKM's NMIMS Deemed-to-be University, Shirpur, Maharashtra, 425405, India.
Inflammopharmacology
|June 20, 2025
概括
植物衍生化合物Tectoridin在治疗代谢综合征 (MetS) 中表现出显著的潜力. 这项研究证明了其多目标治疗效果,改善了关键的代谢标记物,并验证了其作为植物药物候选物的使用.
科学领域:
- 药理学和传统医学的医学.
- 计算生物学和生物信息学
- 生物化学和分子生物学
背景情况:
- 民族药理学研究了疾病的传统植物性疗法.
- 代谢综合征 (MetS) 是一种复杂的疾病,需要多重目标治疗.
- 来自Pueraria thunbergiana和Iris tectorum的异黄Tectoridin已经显示出对代谢途径调节的潜力.
研究的目的:
- 探索Tectoridin对代谢综合征 (MetS) 的治疗潜力.
- 通过综合实验和计算方法研究Tectoridin的多目标机制.
- 评估Tectoridin在MetS的临床前模型中的疗效.
主要方法:
- 网络药理学和蛋白质与蛋白质相互作用 (PPI) 分析以确定关键的MetS相关基因.
- 分子对接以评估Tectoridin与已识别的标蛋白的结合亲和力.
- 在体内验证使用高脂肪饮食 - 链毒素 (HFD-STZ) 诱导的MetS大鼠模型.
主要成果:
- 确定EGFR,HSP90AA1,PPARG,TNF-α和ESR1作为MetS中的关键枢纽基因.
- 德克托里丁与这些关键标具有强烈的结合 afinities.
- 在体内研究表明,Tectoridin显著改善了BMI,葡萄糖水平,脂质概况和肝脏健康,同时调节了目标基因表达.
结论:
- 德克托里丁表明对代谢综合征有显著的治疗作用.
- 它的多目标作用表明,它有可能成为一种新的植物药物,用于MetS管理.
- 建议进行进一步的临床研究,以验证Tectoridin在人类患者中的疗效.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K

